Aquilo Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,194,237
| Closed | -$23.6M | – | 16 |
|
|
2021
Q2 | $23.6M | Buy |
1,194,237
+70,000
| +6% | +$1.38M | 6.12% | 7 |
|
|
2021
Q1 | $32.7M | Buy |
1,124,237
+118,703
| +12% | +$3.45M | 5.91% | 4 |
|
|
2020
Q4 | $30.5M | Sell |
1,005,534
-12,800
| -1% | -$388K | 6.33% | 3 |
|
|
2020
Q3 | $16.2M | Sell |
1,018,334
-76,850
| -7% | -$1.22M | 1.72% | 7 |
|
|
2020
Q2 | $21.6M | Buy |
1,095,184
+48,000
| +5% | +$948K | 4.36% | 7 |
|
|
2020
Q1 | $12.9M | Buy |
+1,047,184
| New | +$12.9M | 5.03% | 7 |
|